Sergey Shtrigol

“Efficacy of Revul is demonstrated in our research on bleeding models of different localizations, including heavy arterial bleeding model.
REVUL approved itself as an efficient hemostatic, has shown positive profile of influence on laboratory parameters, which characterize hemostasis system.
In comparison with its analogues, Revul exceeds in terms of safety, because it has no anaphylactogenic properties.”